Dr. Öğr. Üyesi EMEL BAŞAK GENCER AKÇOK

Yayın Ağı

SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler 11

Rapamycin and Niacin combination induces apoptosis and cell cycle arrest through autophagy activation on acute myeloid leukemia cells

Subay L. B., Gencer Akçok E. B., Akçok İ.

Molecular Biology Reports , cilt.52, sa.1, 2025 (SCI-Expanded)

Tomatidine, a Steroidal Alkaloid, Synergizes with Cisplatin to Inhibit Cell Viability and Induce Cell Death Selectively on FLT3-ITD+ Acute Myeloid Leukemia Cells

Ayvaz H. B., Yenigül M., Gencer Akçok E. B.

Cell Biochemistry and Biophysics , cilt.82, sa.3, ss.2889-2900, 2024 (SCI-Expanded) Sürdürülebilir Kalkınma

Inhibition of PI3K-AKT-mTOR pathway and modulation of histone deacetylase enzymes reduce the growth of acute myeloid leukemia cells

Şansaçar M., Sağır H., GENCER AKÇOK E. B.

Medical Oncology , cilt.41, sa.1, 2024 (SCI-Expanded)

Histone Deacetylase Inhibition and Autophagy Modulation Induces a Synergistic Antiproliferative Effect and Cell Death in Cholangiocarcinoma Cells

Yenigül M., GENCER AKÇOK E. B.

ACS Omega , cilt.8, sa.24, ss.21755-21768, 2023 (SCI-Expanded)

Ethacrynic acid and cinnamic acid combination exhibits selective anticancer effects on K562 chronic myeloid leukemia cells

Yenigul M., AKÇOK İ., GENCER AKÇOK E. B.

MOLECULAR BIOLOGY REPORTS , cilt.49, sa.8, ss.7521-7530, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

Investigation of the Antitumor Effect of Targeting PI3K-AKT-mTOR Pathway and Histone Deacetylase Enzymes on Acute Myeloid Leukemia Cells

ŞANSAÇAR M., Sagir H., GENCER AKÇOK E. B.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , cilt.21, 2021 (SCI-Expanded)

Dissection of the BCR-ABL signaling network using highly specific monobody inhibitors to the SHP2 SH2 domains

Sha F., Gencer E. B., Georgeon S., Koide A., Yasui N., Koide S., et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA , cilt.110, sa.37, ss.14924-14929, 2013 (SCI-Expanded)

Mechanisms of resistance to BCR-ABL and other kinase inhibitors

Lamontanara A. J., Gencer E. B., Kuzyk O., Hantschel O.

BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS , cilt.1834, sa.7, ss.1449-1459, 2013 (SCI-Expanded)

Mechanisms responsible for nilotinib resistance in human chronic myeloid leukemia cells and reversal of resistance

Camgoz A., Gencer E. B., Ural A. U., Baran Y.

LEUKEMIA & LYMPHOMA , cilt.54, sa.6, ss.1279-1287, 2013 (SCI-Expanded)

A novel mechanism of dasatinib-induced apoptosis in chronic myeloid leukemia; ceramide synthase and ceramide clearance genes

Gencer E. B., URAL A. U., AVCU F., Baran Y.

ANNALS OF HEMATOLOGY , cilt.90, sa.11, ss.1265-1275, 2011 (SCI-Expanded)

Roles of ceramide synthase and ceramide clearence genes in nilotinib-induced cell death in chronic myeloidleukemia cells

Camgoz A., Gencer E. B., Ural A. U., AVCU F., Baran Y.

LEUKEMIA & LYMPHOMA , cilt.52, sa.8, ss.1574-1584, 2011 (SCI-Expanded)

Diğer Dergilerde Yayınlanan Makaleler 3

Targeting HDAC enzymes by SAHA enhances the cytotoxic effects of cisplatin on acute myeloid leukemia cells

Şansaçar M., Pekin Ö., Gencer Akçok E. B.

Journal of Experimental and Clinical Medicine (Turkey) , cilt.41, sa.3, ss.524-529, 2024 (Scopus)

Measurement of Autophagic Activity in Cancer Cells with Flow Cytometric Analysis Using Cyto-ID Staining.

Şansaçar M., Gencer Akçok E. B.

Methods in molecular biology (Clifton, N.J.) , 2024 (Scopus)

The therapeutic potential of targeting HDAC6 with Tubastatin A in TFK-1 and EGI-1 cholangiocarcinoma cells

YENİGÜL M., GENCER AKCOK E. B.

Cumhuriyet Science Journal , cilt.42, sa.4, ss.775-780, 2021 (Hakemli Dergi) Sürdürülebilir Kalkınma

Metrikler

Yayın

Atıf (WoS)

132

H-İndeks (WoS)

Atıf (Scopus)

234

H-İndeks (Scopus)

Proje

Tez Danışmanlığı

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler